The Role of High-Density Lipoprotein in COVID-19
The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst reducing the fatality rate and dealing with complications, brings unique difficulties. The most striking pathophysiological features of pati...
Saved in:
Published in | Frontiers in pharmacology Vol. 12; p. 720283 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
16.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst reducing the fatality rate and dealing with complications, brings unique difficulties. The most striking pathophysiological features of patients with severe COVID-19 are dysregulated immune responses and abnormal coagulation function, which can result in multiple-organ failure and death. Normally metabolized high-density lipoprotein (HDL) performs several functions, including reverse cholesterol transport, direct binding to lipopolysaccharide (LPS) to neutralize LPS activity, regulation of inflammatory response, anti-thrombotic effects, antioxidant, and anti-apoptotic properties. Clinical data shows that significantly decreased HDL levels in patients with COVID-19 are correlated with both disease severity and mortality. However, the role of HDL in COVID-19 and its specific mechanism remain unclear. In this analysis, we review current evidence mainly in the following areas: firstly, the pathophysiological characteristics of COVID-19, secondly, the pleiotropic properties of HDL, thirdly, the changes and clinical significance of HDL in COVID-19, and fourthly the prospect of HDL-targeting therapy in COVID-19 to clarify the role of HDL in the pathogenesis of COVID-19 and discuss the potential of HDL therapy in COVID-19. |
---|---|
AbstractList | The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst reducing the fatality rate and dealing with complications, brings unique difficulties. The most striking pathophysiological features of patients with severe COVID-19 are dysregulated immune responses and abnormal coagulation function, which can result in multiple-organ failure and death. Normally metabolized high-density lipoprotein (HDL) performs several functions, including reverse cholesterol transport, direct binding to lipopolysaccharide (LPS) to neutralize LPS activity, regulation of inflammatory response, anti-thrombotic effects, antioxidant, and anti-apoptotic properties. Clinical data shows that significantly decreased HDL levels in patients with COVID-19 are correlated with both disease severity and mortality. However, the role of HDL in COVID-19 and its specific mechanism remain unclear. In this analysis, we review current evidence mainly in the following areas: firstly, the pathophysiological characteristics of COVID-19, secondly, the pleiotropic properties of HDL, thirdly, the changes and clinical significance of HDL in COVID-19, and fourthly the prospect of HDL-targeting therapy in COVID-19 to clarify the role of HDL in the pathogenesis of COVID-19 and discuss the potential of HDL therapy in COVID-19. The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst reducing the fatality rate and dealing with complications, brings unique difficulties. The most striking pathophysiological features of patients with severe COVID-19 are dysregulated immune responses and abnormal coagulation function, which can result in multiple-organ failure and death. Normally metabolized high-density lipoprotein (HDL) performs several functions, including reverse cholesterol transport, direct binding to lipopolysaccharide (LPS) to neutralize LPS activity, regulation of inflammatory response, anti-thrombotic effects, antioxidant, and anti-apoptotic properties. Clinical data shows that significantly decreased HDL levels in patients with COVID-19 are correlated with both disease severity and mortality. However, the role of HDL in COVID-19 and its specific mechanism remain unclear. In this analysis, we review current evidence mainly in the following areas: firstly, the pathophysiological characteristics of COVID-19, secondly, the pleiotropic properties of HDL, thirdly, the changes and clinical significance of HDL in COVID-19, and fourthly the prospect of HDL-targeting therapy in COVID-19 to clarify the role of HDL in the pathogenesis of COVID-19 and discuss the potential of HDL therapy in COVID-19.The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst reducing the fatality rate and dealing with complications, brings unique difficulties. The most striking pathophysiological features of patients with severe COVID-19 are dysregulated immune responses and abnormal coagulation function, which can result in multiple-organ failure and death. Normally metabolized high-density lipoprotein (HDL) performs several functions, including reverse cholesterol transport, direct binding to lipopolysaccharide (LPS) to neutralize LPS activity, regulation of inflammatory response, anti-thrombotic effects, antioxidant, and anti-apoptotic properties. Clinical data shows that significantly decreased HDL levels in patients with COVID-19 are correlated with both disease severity and mortality. However, the role of HDL in COVID-19 and its specific mechanism remain unclear. In this analysis, we review current evidence mainly in the following areas: firstly, the pathophysiological characteristics of COVID-19, secondly, the pleiotropic properties of HDL, thirdly, the changes and clinical significance of HDL in COVID-19, and fourthly the prospect of HDL-targeting therapy in COVID-19 to clarify the role of HDL in the pathogenesis of COVID-19 and discuss the potential of HDL therapy in COVID-19. |
Author | Wu, Shangjie Wu, Chenfang Wang, Guyi Li, Jinxiu Zhong, Yanjun Dong, Haiyun Deng, Jiayi |
AuthorAffiliation | 1 Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha , China 2 Department of Respiratory, The Second Xiangya Hospital, Central South University, Changsha , China |
AuthorAffiliation_xml | – name: 1 Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha , China – name: 2 Department of Respiratory, The Second Xiangya Hospital, Central South University, Changsha , China |
Author_xml | – sequence: 1 givenname: Guyi surname: Wang fullname: Wang, Guyi – sequence: 2 givenname: Jiayi surname: Deng fullname: Deng, Jiayi – sequence: 3 givenname: Jinxiu surname: Li fullname: Li, Jinxiu – sequence: 4 givenname: Chenfang surname: Wu fullname: Wu, Chenfang – sequence: 5 givenname: Haiyun surname: Dong fullname: Dong, Haiyun – sequence: 6 givenname: Shangjie surname: Wu fullname: Wu, Shangjie – sequence: 7 givenname: Yanjun surname: Zhong fullname: Zhong, Yanjun |
BookMark | eNp9kU1r3DAQhkVJaNI0P6A3H3vx1prR56VQNm2zsBAoSa5ClqVdBa_lSt5A_n292RCaHjqIkZiZ9xnB-4GcDGnwhHyizQJR6S9h3Nq8gAboQs5Z4TtyToXAWisKJ3-9z8hlKQ_NHKg1CvaenCFD5CD1OWlut776lXpfpVBdx822vvJDidNTtY5jGnOafByq-Sxv7ldXNdUfyWmwffGXL_cFufvx_XZ5Xa9vfq6W39a1YwymWnI5r7AIGlTDqbXQAVOoAgTtUFrBWesVtSAEcI-tCG0QoREOqA2sa_GCrI7cLtkHM-a4s_nJJBvNcyHljbF5iq73xokWtHVBiE4xrg6A1jLpwDUo2k7PrK9H1rhvd75zfpiy7d9A33aGuDWb9GgUAjBUM-DzCyCn33tfJrOLxfm-t4NP-2KAc8lRKuDzKD2OupxKyT68rqGNORhnno0zB-PM0bhZI__RuDjZKabDb2L_H-UfFXWdAA |
CitedBy_id | crossref_primary_10_3390_biology12060852 crossref_primary_10_36485_1561_6274_2024_28_1_13_29 crossref_primary_10_53696_27214834_733 crossref_primary_10_3390_biomedicines10092320 crossref_primary_10_3390_ijms251910489 crossref_primary_10_1155_2023_6329873 crossref_primary_10_3389_fmicb_2023_1239420 crossref_primary_10_3389_fphar_2022_1003469 crossref_primary_10_17721_1728_2748_2023_92_22_26 crossref_primary_10_3390_jcm10245955 crossref_primary_10_3390_v14092067 crossref_primary_10_2147_IJGM_S346690 crossref_primary_10_3390_antiox11101858 crossref_primary_10_1016_j_arteri_2021_11_006 crossref_primary_10_31450_ukrjnd_1_73__2022_03 crossref_primary_10_1055_a_1860_2610 crossref_primary_10_26508_lsa_202302453 |
Cites_doi | 10.1093/eurheartj/ehx665 10.1038/s41598-020-72718-9 10.1016/j.rmed.2020.106218 10.1002/jmv.26424 10.1161/circulationaha.104.521344 10.1016/s2213-2600(20)30076-x 10.14740/jocmr3362w 10.1002/jlb.4hi0720-470r 10.1016/j.diabres.2005.03.013 10.1016/j.clim.2020.108603 10.1186/s12879-020-05678-0 10.1084/jem.184.5.1601 10.3389/fphys.2020.00747 10.1074/jbc.M109.020933 10.1016/S0140-6736(20)30183-5 10.1016/S0022-2275(20)35189-0 10.1111/imm.13223 10.1002/jmv.26742 10.1016/j.jlr.2021.100061 10.1074/jbc.M103782200 10.2147/dmso.s268992 10.1161/01.cir.103.18.2283 10.1097/qad.0000000000001642 10.1093/gerona/glr016 10.1016/j.jacl.2020.04.008 10.1016/j.cca.2020.07.015 10.1016/j.hrtlng.2021.01.016 10.1093/cid/ciaa248 10.1159/000347077 10.1001/jama.2020.1585 10.1038/89986 10.3390/antiox9100936 10.1038/s41586-020-2012-7 10.1128/iai.28.2.373-380.1980 10.1101/2020.02.25.20027664 10.1016/j.bbalip.2020.158849 10.1371/journal.pone.0239573 10.1016/j.jdiacomp.2020.107666 10.5551/jat.13532 10.1111/jth.14768 10.1172/jci109610 10.1186/s12879-020-05242-w 10.1016/j.ijid.2020.02.043 10.1038/ni.2784 10.1016/j.clim.2020.108450 10.1016/s0002-9149(03)00615-5 10.1161/circresaha.114.300935 10.1111/j.1538-7836.2010.03744.x 10.1056/NEJMoa2015432 10.1186/s40064-016-2685-4 10.1016/j.xcrm.2020.100137 10.1161/01.res.0000054201.60308.1a 10.1056/NEJMoa2002032 10.1185/030079904125004105 10.1097/01.ccm.0000171183.79525.6b 10.1016/j.ijid.2020.01.009 10.14744/AnatolJCardiol.2017.7608 10.3390/microorganisms9010159 10.1161/circulationaha.110.961193 10.17843/rpmesp.2018.351.3568 10.1007/s00392-007-0611-z 10.1097/meg.0000000000001902 10.14715/cmb/2020.66.3.8 10.2337/diacare.25.2.353 10.1016/j.metabol.2005.07.012 10.1016/j.atherosclerosis.2007.10.018 10.1155/2020/9238696 10.1161/circulationaha.105.607135 10.1371/journal.ppat.1000276 10.3389/fgene.2020.586308 10.1161/hc3501.095214 10.1253/circj.CJ-20-0348 10.1080/21505594.2021.1898790 10.1038/s42255-020-00324-0 10.1186/1476-511x-8-59 10.1096/fj.202001451 10.1172/jci31539 10.1152/ajpendo.00255.2020 10.1016/s0021-9258(18)99066-6 10.1161/01.res.0000124302.20396.b7 10.1016/j.jinf.2020.02.010 10.1016/s0889-8529(05)70023-2 10.1111/j.1365-2362.2010.02269.x 10.1038/28406 10.1074/jbc.M112.442699 10.1186/s12944-020-01382-9 10.1073/pnas.90.24.12040 10.1038/s41419-021-03527-9 10.1002/jmv.25678 10.1086/647494 10.1101/2021.01.20.21250152 10.17219/acem/130606 10.3389/fcvm.2020.584987 10.3760/cma.j.cn112151-20200312-00193 10.1016/j.mad.2021.111433 10.1086/649560 10.1515/cclm.2010.218 10.26355/eurrev_202004_20875 10.1186/s13054-020-02860-3 10.1186/s13613-017-0284-3 10.1136/bmjopen-2020-040402 10.1172/jci5006 10.1007/s00011-020-01389-z 10.1038/s41598-021-81638-1 10.1016/j.jcrc.2016.11.041 10.1016/j.cca.2021.02.011 10.1073/pnas.2011086117 10.1016/j.metabol.2020.154437 10.1016/j.cjtee.2020.06.002 10.1183/16000617.0240-2020 10.1097/01.shk.0000097249.97298.a3 10.1016/s0002-9149(03)00530-7 10.1074/jbc.M807286200 10.1177/0885066618772825 10.1001/jama.2020.3204 10.1002/fsn3.1907 10.1097/01.ccm.0000059724.08290.51 10.1055/a-1169-4443 10.1007/s11427-020-1733-4 10.1164/rccm.201806-1157OC 10.1046/j.1365-2141.2001.03061.x 10.1161/01.cir.79.1.8 10.1128/iai.63.1.253-258.1995 10.1080/22221751.2020.1747363 10.1054/clnu.2002.0575 10.3390/antiox10020209 10.1161/01.atv.17.10.2158 10.1097/aln.0000000000003155 10.1096/fj.02-0240fje 10.1016/j.clim.2021.108716 10.1016/s0140-6736(20)30566-3 10.1161/circulationaha.120.048568 10.1016/j.arcmed.2021.06.004 10.1007/978-3-319-09665-0_15 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong. Copyright © 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong. 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong |
Copyright_xml | – notice: Copyright © 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong. – notice: Copyright © 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong. 2021 Wang, Deng, Li, Wu, Dong, Wu and Zhong |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fphar.2021.720283 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Wang et al |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_c6b29acf66d84581af4ba47c2c036bd9 PMC8322438 10_3389_fphar_2021_720283 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c442t-757335a32928051aa2d24838f2f9c37a654be81a26625e3b6fbf6f06c21af4db3 |
IEDL.DBID | M48 |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:31:13 EDT 2025 Thu Aug 21 13:46:06 EDT 2025 Fri Jul 11 05:09:07 EDT 2025 Tue Jul 01 03:27:29 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-757335a32928051aa2d24838f2f9c37a654be81a26625e3b6fbf6f06c21af4db3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Abhigyan Satyam, Harvard Medical School, United States Kristen M. Tecson, Baylor Scott & White Research Institute (BSWRI), United States This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Edited by: Brijesh Kumar Singh, Duke-NUS Medical School, Singapore |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2021.720283 |
PMID | 34335279 |
PQID | 2557537825 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c6b29acf66d84581af4ba47c2c036bd9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8322438 proquest_miscellaneous_2557537825 crossref_primary_10_3389_fphar_2021_720283 crossref_citationtrail_10_3389_fphar_2021_720283 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-07-16 |
PublicationDateYYYYMMDD | 2021-07-16 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-16 day: 16 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in pharmacology |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Delgado-Rodríguez (B22) 1997; 18 Chambers (B14) 2020; 2020 Ouyang (B73) 2020; 20 Xie (B125) 2020; 84 Colantuoni (B19) 2020; 11 Griffin (B30) 1999; 103 Park (B75) 2011 Tanaka (B103); 132 Hamer (B36) 2020; 117 Madsen (B61) 2018; 39 Gordon (B29) 1989; 79 Diurno (B24) 2020; 24 Wang (B117); 20 Xu (B127) 2020; 8 Jones (B48) 2003; 92 Tanaka (B100) 2017; 7 Huang (B41) 2020; 395 Shor (B93) 2008; 97 Mahamid (B62) 2020 Li (B57) 2021; 517 Mastaglio (B63) 2020; 215 Montero-Chacón (B67) 2020; 35 Cho (B16) 2021; 10 Satyam (B88) 2020; 221 Theilmeier (B105) 2006; 114 Levine (B55) 1993; 90 Deguchi (B21) 2005; 112 Yao (B129) 2020; 49 Tanaka (B101); 24 Ulevitch (B111) 1979; 64 Lin (B58) 2020; 23 Rader (B80) 2003; 92 Satyam (B89) 2021; 226 Calabresi (B11) 2003; 92 Jia (B47) 2009; 8 Rodríguez-Sanz (B82) 2013; 35 Zhang (B133) 2020; 13 Wei (B121) 2020; 14 Nardacci (B68) 2021; 12 Sorokin (B95) 2020; 34 Ferretti (B25) 2003 Guo (B34) 2009; 284 Jamal (B45) 2021; 12 Rose (B84) 2008; 199 Suc (B96) 1997; 17 Cirstea (B17) 2017; 38 Guo (B35) 2013; 288 Trinder (B109) 2021; 143 Oslakovic (B72) 2010; 8 De Nardo (B20) 2014; 15 Trinder (B108) 2019; 199 Hilser (B38) 2021; 62 Giunta (B28) 2020; 52 Lassale (B54) 2021 Viswambharan (B115) 2004; 94 Aragonès (B4) 2010; 48 Van Lenten (B113) 2001; 103 Wei (B119); 2 Han (B37) 2020; 80 McDonald (B64) 2003; 20 Song (B94) 2020; 10 Xiong (B126) 2020; 9 Kočar (B52) 2021; 1866 Zhang (B136) 2021; 194 Yanai (B128) 2018; 10 Mehri (B65) 2021 Wei (B120) Wang (B118) 2020; 19 Parker (B76) 1995; 63 Canturk (B12) 2002; 21 Shenoy (B91) 2020; 69 Lu (B59) 2020; 92 José (B49) 2020; 29 Tijburg (B106) 1991; 266 Zhou (B137) 2020; 395 Aung (B5) 2020; 11 Samanovic (B86) 2009; 5 Ackermann (B1) 2020; 383 Ni (B69) 2020; 66 Zhou (B138) 2020; 579 Freudenberg (B26) 1980; 28 Huang (B42) 2021; 30 Pajkrt (B74) 1996; 184 Sharrett (B90) 2001; 104 Grion (B31) 2010; 40 Turgay Yıldırım (B110) 2021; 50 Van Sickle (B114) 1986; 27 Cao (B13) 2020; 319 Guan (B33); 382 Rosenson (B85) 2005; 68 Pirillo (B77) 2015; 224 Guan (B32); 55 Yuhanna (B131) 2001; 7 Cai (B10) 2008; 118 Wang (B116); 323 Li (B56) 2021; 93 B123 B124 B122 Kerr (B51) 2001; 115 Oslakovic (B71) 2009; 284 Nofer (B70) 2001; 276 Robbesyn (B81) 2003; 17 Zhang (B134) 2021; 109 Qin (B79); 71 Miller (B66) 2004; 20 Sasaki (B87) 2013; 20 Huang (B43) 2020; 63 Qin (B78); 8 Tang (B104) 2020; 18 Begue (B8) 2021; 11 Kawasaki (B50) 2002; 25 Rose (B83) 2006; 55 Tosheska Trajkovska (B107) 2017; 18 Tan (B99) 2020; 160 Ji (B46) 2021; 115 Zafer (B132) 2021; 9 Cizmecioglu (B18) 2021; 93 Baker (B6) 2010; 201 Ding (B23) 2020; 175 Kost-Alimova (B53) 2020; 1 Beltrán-García (B9) 2020; 9 Lüscher (B60) 2014; 114 van Leeuwen (B112) 2003; 31 Angelovich (B3) 2017; 31 Hui (B44) 2020; 91 Albarello (B2) 2020; 93 Chien (B15) 2005; 33 Young (B130) 2020; 323 Shih (B92) 1998; 394 Ho (B39) 2020; 10 Suzuki (B98) 2010; 122 Tanaka (B102); 15 Hu (B40) 2020; 510 Ginsberg (B27) 1998; 27 Zou (B139) 2016; 5 Zhang (B135) 2020; 34 Barrientos-Arenas (B7) 2018; 35 Sun (B97) 2020; 7 |
References_xml | – volume: 39 start-page: 1181 year: 2018 ident: B61 article-title: U-shaped Relationship of HDL and Risk of Infectious Disease: Two Prospective Population-Based Cohort Studies publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehx665 – volume: 10 start-page: 15838 year: 2020 ident: B94 article-title: Immune Dysfunction Following COVID-19, Especially in Severe Patients publication-title: Sci. Rep. doi: 10.1038/s41598-020-72718-9 – volume: 175 start-page: 106218 year: 2020 ident: B23 article-title: High-density Lipoprotein Cholesterol as a Factor Affecting Virus Clearance in Covid-19 Patients publication-title: Respir. Med. doi: 10.1016/j.rmed.2020.106218 – volume: 93 start-page: 1449 year: 2021 ident: B56 article-title: Epidemiology of COVID‐19: A Systematic Review and Meta‐analysis of Clinical Characteristics, Risk Factors, and Outcomes publication-title: J. Med. Virol. doi: 10.1002/jmv.26424 – volume: 112 start-page: 893 year: 2005 ident: B21 article-title: High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated with Venous Thrombosis in Men publication-title: Circulation doi: 10.1161/circulationaha.104.521344 – volume: 8 start-page: 420 year: 2020 ident: B127 article-title: Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome publication-title: Lancet Respir. Med. doi: 10.1016/s2213-2600(20)30076-x – volume: 10 start-page: 281 year: 2018 ident: B128 article-title: An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids publication-title: J. Clin. Med. Res. doi: 10.14740/jocmr3362w – volume: 109 start-page: 13 year: 2021 ident: B134 article-title: Frontline Science: COVID‐19 Infection Induces Readily Detectable Morphologic and Inflammation‐related Phenotypic Changes in Peripheral Blood Monocytes publication-title: J. Leukoc. Biol. doi: 10.1002/jlb.4hi0720-470r – volume-title: Coronavirus Disease (COVID-19) Situation Dashboard of China ident: B123 – volume: 68 start-page: S36 year: 2005 ident: B85 article-title: HDL-C and the Diabetic Patient: Target for Therapeutic Intervention? publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2005.03.013 – volume: 221 start-page: 108603 year: 2020 ident: B88 article-title: Curb Complement to Cure COVID-19 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2020.108603 – volume: 20 start-page: 952 year: 2020 ident: B73 article-title: Temporal Changes in Laboratory Markers of Survivors and Non-survivors of Adult Inpatients with COVID-19 publication-title: BMC Infect. Dis. doi: 10.1186/s12879-020-05678-0 – volume: 184 start-page: 1601 year: 1996 ident: B74 article-title: Antiinflammatory Effects of Reconstituted High-Density Lipoprotein during Human Endotoxemia publication-title: J. Exp. Med. doi: 10.1084/jem.184.5.1601 – volume: 11 start-page: 747 year: 2020 ident: B19 article-title: COVID-19 Sepsis and Microcirculation Dysfunction publication-title: Front. Physiol. doi: 10.3389/fphys.2020.00747 – volume: 284 start-page: 19826 year: 2009 ident: B34 article-title: Scavenger Receptor BI Protects against Septic Death through its Role in Modulating Inflammatory Response publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.020933 – volume: 395 start-page: 497 year: 2020 ident: B41 article-title: Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China publication-title: The Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 27 start-page: 517 year: 1986 ident: B114 article-title: High Density Lipoprotein-Induced Cardiac Prostacyclin Synthesis In Vitro: Relationship to Cardiac Arachidonate Mobilization publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)35189-0 – volume: 160 start-page: 261 year: 2020 ident: B99 article-title: Immunopathological Characteristics of Coronavirus Disease 2019 Cases in Guangzhou, China publication-title: Immunology doi: 10.1111/imm.13223 – volume: 93 start-page: 2867 year: 2021 ident: B18 article-title: Apoptosis‐induced T‐cell Lymphopenia Is Related to COVID‐19 Severity publication-title: J. Med. Virol. doi: 10.1002/jmv.26742 – volume: 62 start-page: 100061 year: 2021 ident: B38 article-title: Association of Serum HDL-Cholesterol and Apolipoprotein A1 Levels with Risk of Severe SARS-CoV-2 Infection publication-title: J. lipid Res. doi: 10.1016/j.jlr.2021.100061 – volume: 276 start-page: 34480 year: 2001 ident: B70 article-title: Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-Associated Lysosphingolipids publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103782200 – volume: 13 start-page: 3925 year: 2020 ident: B133 article-title: Triglyceride to High-Density Lipoprotein Cholesterol Ratio Is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study publication-title: Dmso doi: 10.2147/dmso.s268992 – volume: 103 start-page: 2283 year: 2001 ident: B113 article-title: High-density Lipoprotein Loses its Anti-inflammatory Properties during Acute Influenza a Infection publication-title: Circulation doi: 10.1161/01.cir.103.18.2283 – volume: 31 start-page: 2331 year: 2017 ident: B3 article-title: Dysfunctional High-Density Lipoprotein from HIV+ Individuals Promotes Monocyte-Derived Foam Cell Formation In Vitro publication-title: Aids doi: 10.1097/qad.0000000000001642 – start-page: 511 year: 2011 ident: B75 article-title: High-density Lipoprotein (HDL) from Elderly and Reconstituted HDL Containing Glycated Apolipoproteins A-I Share Proatherosclerotic and Prosenescent Properties with Increased Cholesterol Influx publication-title: Journals Gerontol. Ser. A: Biol. Sci. Med. Sci. doi: 10.1093/gerona/glr016 – volume: 14 start-page: 297 year: 2020 ident: B121 article-title: Hypolipidemia Is Associated with the Severity of COVID-19 publication-title: J. Clin. Lipidol. doi: 10.1016/j.jacl.2020.04.008 – volume: 510 start-page: 105 year: 2020 ident: B40 article-title: Declined Serum High Density Lipoprotein Cholesterol Is Associated with the Severity of COVID-19 Infection publication-title: Clinica Chim. Acta doi: 10.1016/j.cca.2020.07.015 – volume: 50 start-page: 329 year: 2021 ident: B110 article-title: The Atherogenic index of Plasma as a Predictor of Mortality in Patients with COVID-19 publication-title: Heart Lung : J. Crit. Care doi: 10.1016/j.hrtlng.2021.01.016 – volume: 71 start-page: 762 ident: B79 article-title: Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa248 – volume: 35 start-page: 291 year: 2013 ident: B82 article-title: High-density Lipoprotein: a Novel Marker for Risk of In-Hospital Infection in Acute Ischemic Stroke Patients? publication-title: Cerebrovasc. Dis. doi: 10.1159/000347077 – volume: 323 start-page: 1061 ident: B116 article-title: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China publication-title: Jama doi: 10.1001/jama.2020.1585 – volume: 7 start-page: 853 year: 2001 ident: B131 article-title: High-Density Lipoprotein Binding to Scavenger Receptor-BI Activates Endothelial Nitric Oxide Synthase publication-title: Nat. Med. doi: 10.1038/89986 – volume: 9 start-page: 936 year: 2020 ident: B9 article-title: Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-oxidant Therapy in Avoiding Disease Progression publication-title: Antioxidants doi: 10.3390/antiox9100936 – volume: 579 start-page: 270 year: 2020 ident: B138 article-title: A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 – volume: 28 start-page: 373 year: 1980 ident: B26 article-title: Interaction of Lipopolysaccharides with Plasma High-Density Lipoprotein in Rats publication-title: Infect. Immun. doi: 10.1128/iai.28.2.373-380.1980 – volume: 55 start-page: 20027664 ident: B32 article-title: Comorbidity and its Impact on 1,590 Patients with COVID-19 in China: A Nationwide Analysis publication-title: Eur. Respir. J. doi: 10.1101/2020.02.25.20027664 – volume: 1866 start-page: 158849 year: 2021 ident: B52 article-title: Cholesterol, Lipoproteins, and COVID-19: Basic Concepts and Clinical Applications publication-title: Biochim. Biophys. Acta Mol. Cel Biol Lipids doi: 10.1016/j.bbalip.2020.158849 – volume: 15 start-page: e0239573 ident: B102 article-title: Lipoprotein Concentrations Over Time in the Intensive Care Unit COVID-19 Patients: Results from the ApoCOVID Study publication-title: PloS one doi: 10.1371/journal.pone.0239573 – volume: 34 start-page: 107666 year: 2020 ident: B135 article-title: Clinical Analysis of Risk Factors for Severe COVID-19 Patients With Type 2 Diabetes publication-title: J. Diabetes Complications doi: 10.1016/j.jdiacomp.2020.107666 – start-page: 25 year: 2003 ident: B25 article-title: Protective Effect of Human HDL against Cu(2+)-Induced Oxidation of Astrocytes publication-title: J. Trace Elem. Med. Biol. – volume: 20 start-page: 368 year: 2013 ident: B87 article-title: Effects of Pravastatin and Atorvastatin on HDL Cholesterol and Glucose Metabolism in Patients with Dyslipidemia and Glucose Intolerance: the PRAT Study publication-title: Jat doi: 10.5551/jat.13532 – volume: 18 start-page: 844 year: 2020 ident: B104 article-title: Abnormal Coagulation Parameters Are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia publication-title: J. Thromb. Haemost. doi: 10.1111/jth.14768 – volume: 64 start-page: 1516 year: 1979 ident: B111 article-title: New Function for High Density Lipoproteins. Their Participation in Intravascular Reactions of Bacterial Lipopolysaccharides publication-title: J. Clin. Invest. doi: 10.1172/jci109610 – volume: 20 start-page: 519 ident: B117 article-title: Correlation Analysis between Disease Severity and Clinical and Biochemical Characteristics of 143 Cases of COVID-19 in Wuhan, China: a Descriptive Study publication-title: BMC Infect. Dis. doi: 10.1186/s12879-020-05242-w – volume: 93 start-page: 192 year: 2020 ident: B2 article-title: 2019-novel Coronavirus Severe Adult Respiratory Distress Syndrome in Two Cases in Italy: An Uncommon Radiological Presentation publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.02.043 – volume: 15 start-page: 152 year: 2014 ident: B20 article-title: High-Density Lipoprotein Mediates Anti-inflammatory Reprogramming of Macrophages Via the Transcriptional Regulator ATF3 publication-title: Nat. Immunol. doi: 10.1038/ni.2784 – volume: 215 start-page: 108450 year: 2020 ident: B63 article-title: The First Case of COVID-19 Treated with the Complement C3 Inhibitor AMY-101 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2020.108450 – volume: 92 start-page: 42 year: 2003 ident: B80 article-title: Regulation of Reverse Cholesterol Transport and Clinical Implications publication-title: Am. J. Cardiol. doi: 10.1016/s0002-9149(03)00615-5 – volume: 114 start-page: 171 year: 2014 ident: B60 article-title: High-Density Lipoprotein publication-title: Circ. Res. doi: 10.1161/circresaha.114.300935 – volume: 8 start-page: 766 year: 2010 ident: B72 article-title: The Role of Phospholipid Transfer Protein in Lipoprotein-Mediated Neutralization of the Procoagulant Effect of Anionic Liposomes publication-title: J. Thromb. Haemost. : JTH doi: 10.1111/j.1538-7836.2010.03744.x – volume: 383 start-page: 120 year: 2020 ident: B1 article-title: Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2015432 – volume-title: Coronavirus Disease (COVID-19) Situation Dashboard of United States of America ident: B124 – volume: 5 start-page: 1044 year: 2016 ident: B139 article-title: The delta High-Density Lipoprotein Cholesterol Ratio: A Novel Parameter for Gram-Negative Sepsis publication-title: Springerplus doi: 10.1186/s40064-016-2685-4 – volume: 1 start-page: 100137 year: 2020 ident: B53 article-title: A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury publication-title: Cel Rep. Med. doi: 10.1016/j.xcrm.2020.100137 – volume: 92 start-page: 330 year: 2003 ident: B11 article-title: High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-α Content and Enhancing Prostaglandin Release publication-title: Circ. Res. doi: 10.1161/01.res.0000054201.60308.1a – volume: 382 start-page: 1708 ident: B33 article-title: Clinical Characteristics of Coronavirus Disease 2019 in China publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002032 – volume: 20 start-page: 1087 year: 2004 ident: B66 article-title: Effectiveness of Simvastatin Therapy in Raising HDL-C in Patients with Type 2 Diabetes and Low HDL-C publication-title: Curr. Med. Res. Opin. doi: 10.1185/030079904125004105 – volume: 33 start-page: 1688 year: 2005 ident: B15 article-title: Low Serum Level of High-Density Lipoprotein Cholesterol Is a Poor Prognostic Factor for Severe Sepsis* publication-title: Crit. Care Med. doi: 10.1097/01.ccm.0000171183.79525.6b – volume: 91 start-page: 264 year: 2020 ident: B44 article-title: The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health - the Latest 2019 Novel Coronavirus Outbreak in Wuhan, China publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.01.009 – volume: 18 start-page: 149 year: 2017 ident: B107 article-title: High-density Lipoprotein Metabolism and Reverse Cholesterol Transport: Strategies for Raising HDL Cholesterol publication-title: Anatol J. Cardiol. doi: 10.14744/AnatolJCardiol.2017.7608 – volume: 9 start-page: 159 year: 2021 ident: B132 article-title: Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers publication-title: Microorganisms doi: 10.3390/microorganisms9010159 – volume: 122 start-page: 1919 year: 2010 ident: B98 article-title: High-density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged with Lipopolysaccharide publication-title: Circulation doi: 10.1161/circulationaha.110.961193 – volume: 35 start-page: 15 year: 2018 ident: B7 article-title: Modulación de los niveles de lipoproteínas de alta densidad y las citoquinas IL-1β e IL-6 en pacientes con dengue publication-title: Rev. Peru Med. Exp. Salud Publica doi: 10.17843/rpmesp.2018.351.3568 – volume: 97 start-page: 227 year: 2008 ident: B93 article-title: Low HDL Levels and the Risk of Death, Sepsis and Malignancy publication-title: Clin. Res. Cardiol. doi: 10.1007/s00392-007-0611-z – volume-title: Coronavirus (COVID-19) Overview ident: B122 – year: 2020 ident: B62 article-title: Nonalcoholic Fatty Liver Disease Is Associated with COVID-19 Severity Independently of Metabolic Syndrome publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/meg.0000000000001902 – volume: 66 start-page: 52 year: 2020 ident: B69 article-title: Parenteral Nutrition Effects of Omega-3 Fatty Acids on C-Reactive Protein, High-Density Lipoprotein, Lymphocyte Characteristics and the Treatment of Critically Ill Patients publication-title: Cel Mol Biol. (Noisy-le-grand) doi: 10.14715/cmb/2020.66.3.8 – volume: 25 start-page: 353 year: 2002 ident: B50 article-title: Increased Fructose Concentrations in Blood and Urine in Patients with Diabetes publication-title: Diabetes Care doi: 10.2337/diacare.25.2.353 – volume: 55 start-page: 90 year: 2006 ident: B83 article-title: HIV Infection and High-Density Lipoprotein: the Effect of the Disease vs the Effect of Treatment publication-title: Metabolism doi: 10.1016/j.metabol.2005.07.012 – volume: 199 start-page: 79 year: 2008 ident: B84 article-title: HIV Infection and High Density Lipoprotein Metabolism publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.10.018 – volume: 2020 start-page: 1 year: 2020 ident: B14 article-title: SARS-CoV-2, Early Entry Events publication-title: J. Pathog. doi: 10.1155/2020/9238696 – volume: 114 start-page: 1403 year: 2006 ident: B105 article-title: High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart against Ischemia/Reperfusion Injury In Vivo via the S1P 3 Lysophospholipid Receptor publication-title: Circulation doi: 10.1161/circulationaha.105.607135 – volume: 5 start-page: e1000276 year: 2009 ident: B86 article-title: Trypanosome Lytic Factor, an Antimicrobial High-Density Lipoprotein, Ameliorates Leishmania Infection publication-title: Plos Pathog. doi: 10.1371/journal.ppat.1000276 – volume: 11 start-page: 586308 year: 2020 ident: B5 article-title: Causal Inference for Genetic Obesity, Cardiometabolic Profile and COVID-19 Susceptibility: A Mendelian Randomization Study publication-title: Front. Genet. doi: 10.3389/fgene.2020.586308 – volume: 104 start-page: 1108 year: 2001 ident: B90 article-title: Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions publication-title: Circulation doi: 10.1161/hc3501.095214 – volume: 84 start-page: 1277 year: 2020 ident: B125 article-title: Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19) publication-title: Circ. J. doi: 10.1253/circj.CJ-20-0348 – volume: 12 start-page: 918 year: 2021 ident: B45 article-title: Immune Dysregulation and System Pathology in COVID-19 publication-title: Virulence doi: 10.1080/21505594.2021.1898790 – volume: 2 start-page: 1391 ident: B119 article-title: HDL-scavenger Receptor B Type 1 Facilitates SARS-CoV-2 Entry publication-title: Nat. Metab. doi: 10.1038/s42255-020-00324-0 – volume: 8 start-page: 59 year: 2009 ident: B47 article-title: Helicobacter pylori Infection Is Associated with Decreased Serum Levels of High Density Lipoprotein, but Not with the Severity of Coronary Atherosclerosis publication-title: Lipids Health Dis. doi: 10.1186/1476-511x-8-59 – volume: 34 start-page: 9843 year: 2020 ident: B95 article-title: COVID‐19-Associated Dyslipidemia: Implications for Mechanism of Impaired Resolution and Novel Therapeutic Approaches publication-title: FASEB j. doi: 10.1096/fj.202001451 – volume: 118 start-page: 364 year: 2008 ident: B10 article-title: SR-BI Protects against Endotoxemia in Mice through its Roles in Glucocorticoid Production and Hepatic Clearance publication-title: J. Clin. Invest. doi: 10.1172/jci31539 – volume: 319 start-page: E197 year: 2020 ident: B13 article-title: Cholesterol: A New Game Player Accelerating Endothelial Injuries Caused by SARS-CoV-2? publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00255.2020 – volume: 266 start-page: 12067 year: 1991 ident: B106 article-title: Activation of the Coagulation Mechanism on Tumor Necrosis Factor-Stimulated Cultured Endothelial Cells and Their Extracellular Matrix. The Role of Flow and Factor IX/IXa publication-title: J. Biol. Chem. doi: 10.1016/s0021-9258(18)99066-6 – volume: 94 start-page: 918 year: 2004 ident: B115 article-title: Reconstituted High-Density Lipoprotein Inhibits Thrombin-Induced Endothelial Tissue Factor Expression through Inhibition of RhoA and Stimulation of Phosphatidylinositol 3-kinase but Not Akt/endothelial Nitric Oxide Synthase publication-title: Circ. Res. doi: 10.1161/01.res.0000124302.20396.b7 – volume: 80 start-page: 373 year: 2020 ident: B37 article-title: Coronavirus 2019-nCoV: A Brief Perspective from the Front Line publication-title: J. Infect. doi: 10.1016/j.jinf.2020.02.010 – volume: 27 start-page: 503 year: 1998 ident: B27 article-title: Lipoprotein Physiology publication-title: Endocrinol. Metab. Clin. North America doi: 10.1016/s0889-8529(05)70023-2 – volume: 40 start-page: 330 year: 2010 ident: B31 article-title: Lipoproteins and CETP Levels as Risk Factors for Severe Sepsis in Hospitalized Patients publication-title: Eur. J. Clin. Invest. doi: 10.1111/j.1365-2362.2010.02269.x – volume: 394 start-page: 284 year: 1998 ident: B92 article-title: Mice Lacking Serum Paraoxonase Are Susceptible to Organophosphate Toxicity and Atherosclerosis publication-title: Nature doi: 10.1038/28406 – volume: 288 start-page: 17947 year: 2013 ident: B35 article-title: High Density Lipoprotein Protects against Polymicrobe-Induced Sepsis in Mice* publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.442699 – volume: 19 start-page: 204 year: 2020 ident: B118 article-title: Low High-Density Lipoprotein Level Is Correlated with the Severity of COVID-19 Patients: an Observational Study publication-title: Lipids Health Dis. doi: 10.1186/s12944-020-01382-9 – volume: 90 start-page: 12040 year: 1993 ident: B55 article-title: In Vivo protection against Endotoxin by Plasma High Density Lipoprotein publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.90.24.12040 – volume: 12 start-page: 263 year: 2021 ident: B68 article-title: Evidences for Lipid Involvement in SARS-CoV-2 Cytopathogenesis publication-title: Cell Death Dis. doi: 10.1038/s41419-021-03527-9 – volume: 92 start-page: 401 year: 2020 ident: B59 article-title: Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and the Miracle publication-title: J. Med. Virol. doi: 10.1002/jmv.25678 – volume: 18 start-page: 9 year: 1997 ident: B22 article-title: Total Cholesterol, HDL-Cholesterol, and Risk of Nosocomial Infection: A Prospective Study in Surgical Patients publication-title: Infect. Control. Hosp. Epidemiol. doi: 10.1086/647494 – year: 2021 ident: B54 article-title: Association of Pre-pandemic High-Density Lipoprotein Cholesterol with Risk of COVID-19 Hospitalisation and Death: the UK Biobank Cohort Study publication-title: medRxiv doi: 10.1101/2021.01.20.21250152 – volume: 30 start-page: 153 year: 2021 ident: B42 article-title: The Clinical Value of High-Density Lipoprotein in the Evaluation of New Coronavirus Pneumonia publication-title: Adv. Clin. Exp. Med. doi: 10.17219/acem/130606 – volume: 7 start-page: 584987 year: 2020 ident: B97 article-title: Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19 publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2020.584987 – volume: 49 start-page: 411 year: 2020 ident: B129 article-title: [A Pathological Report of Three COVID-19 Cases by Minimal Invasive Autopsies] publication-title: Zhonghua Bing Li Xue Za Zhi doi: 10.3760/cma.j.cn112151-20200312-00193 – volume: 194 start-page: 111433 year: 2021 ident: B136 article-title: Association Analysis Framework of Genetic and Exposure Risks for COVID-19 in Middle-Aged and Elderly Adults publication-title: Mech. ageing Dev. doi: 10.1016/j.mad.2021.111433 – volume: 201 start-page: 285 year: 2010 ident: B6 article-title: High‐Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection publication-title: J. Infect. Dis. doi: 10.1086/649560 – volume: 48 start-page: 1147 year: 2010 ident: B4 article-title: Human Immunodeficiency Virus-Infection Induces Major Changes in High-Density Lipoprotein Particle Size Distribution and Composition: The Effect of Antiretroviral Treatment and Disease Severity publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm.2010.218 – volume: 24 start-page: 4040 year: 2020 ident: B24 article-title: Eculizumab Treatment in Patients with COVID-19: Preliminary Results from Real Life ASL Napoli 2 Nord Experience publication-title: Eur. Rev. Med. Pharmacol. Sci. doi: 10.26355/eurrev_202004_20875 – volume: 24 start-page: 134 ident: B101 article-title: High-density Lipoproteins during Sepsis: from Bench to Bedside publication-title: Crit. Care doi: 10.1186/s13054-020-02860-3 – volume: 7 start-page: 60 year: 2017 ident: B100 article-title: Low HDL Levels in Sepsis versus Trauma Patients in Intensive Care Unit publication-title: Ann. Intensive Care doi: 10.1186/s13613-017-0284-3 – volume: 10 start-page: e040402 year: 2020 ident: B39 article-title: Modifiable and Non-modifiable Risk Factors for COVID-19, and Comparison to Risk Factors for Influenza and Pneumonia: Results from a UK Biobank Prospective Cohort Study publication-title: BMJ open doi: 10.1136/bmjopen-2020-040402 – volume: 103 start-page: 219 year: 1999 ident: B30 article-title: High-density Lipoprotein Enhancement of Anticoagulant Activities of Plasma Protein S and Activated Protein C publication-title: J. Clin. Invest. doi: 10.1172/jci5006 – volume: 69 start-page: 1077 year: 2020 ident: B91 article-title: Coronavirus (Covid-19) Sepsis: Revisiting Mitochondrial Dysfunction in Pathogenesis, Aging, Inflammation, and Mortality publication-title: Inflamm. Res. doi: 10.1007/s00011-020-01389-z – volume: 11 start-page: 2291 year: 2021 ident: B8 article-title: Altered High-Density Lipoprotein Composition and Functions During Severe COVID-19 publication-title: Sci. Rep. doi: 10.1038/s41598-021-81638-1 – volume: 38 start-page: 289 year: 2017 ident: B17 article-title: Decreased High-Density Lipoprotein Cholesterol Level Is an Early Prognostic Marker for Organ Dysfunction and Death in Patients with Suspected Sepsis publication-title: J. Crit. Care doi: 10.1016/j.jcrc.2016.11.041 – volume: 517 start-page: 66 year: 2021 ident: B57 article-title: Lipid Metabolism Changes in Patients with Severe COVID-19 publication-title: Clinica Chim. Acta doi: 10.1016/j.cca.2021.02.011 – volume: 117 start-page: 21011 year: 2020 ident: B36 article-title: Overweight, Obesity, and Risk of Hospitalization for COVID-19: A Community-Based Cohort Study of Adults in the United Kingdom publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.2011086117 – volume: 115 start-page: 154437 year: 2021 ident: B46 article-title: Letter to the Editor: Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease Are Proinflammatory Hypercoagulable States Associated with Severe Disease and Thrombosis in Covid-19 publication-title: Metabolism doi: 10.1016/j.metabol.2020.154437 – volume: 23 start-page: 190 year: 2020 ident: B58 article-title: The Severe COVID-19: A Sepsis Induced by Viral Infection? and its Immunomodulatory Therapy publication-title: Chin. J. Traumatol. doi: 10.1016/j.cjtee.2020.06.002 – volume: 29 start-page: 200240 year: 2020 ident: B49 article-title: Targeting Coagulation Activation in Severe COVID-19 Pneumonia: Lessons from Bacterial Pneumonia and Sepsis publication-title: Eur. Respir. Rev. doi: 10.1183/16000617.0240-2020 – volume: 20 start-page: 551 year: 2003 ident: B64 article-title: Reconstituted High-Density Lipoprotein Attenuates Organ Injury and Adhesion Molecule Expression in a Rodent Model of Endotoxic Shock publication-title: Shock doi: 10.1097/01.shk.0000097249.97298.a3 – volume: 92 start-page: 152 year: 2003 ident: B48 article-title: Comparison of the Efficacy and Safety of Rosuvastatin versus Atorvastatin, Simvastatin, and Pravastatin across Doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels Compared across Doses to Rosuvastatin. Trial) publication-title: Am. J. Cardiol. doi: 10.1016/s0002-9149(03)00530-7 – volume: 284 start-page: 5896 year: 2009 ident: B71 article-title: Anionic Phospholipids Lose Their Procoagulant Properties when Incorporated into High Density Lipoproteins publication-title: J. Biol. Chem. doi: 10.1074/jbc.M807286200 – volume: 35 start-page: 636 year: 2020 ident: B67 article-title: High-Density Lipoprotein, Mean Platelet Volume, and Uric Acid as Biomarkers for Outcomes in Patients With Sepsis: An Observational Study publication-title: J. Intensive Care Med. doi: 10.1177/0885066618772825 – volume: 323 start-page: 1488 year: 2020 ident: B130 article-title: Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore publication-title: Jama doi: 10.1001/jama.2020.3204 – volume: 8 start-page: 6144 ident: B78 article-title: Alteration of Lipid Profile and Value of Lipids in the Prediction of the Length of Hospital Stay in COVID‐19 Pneumonia Patients publication-title: Food Sci. Nutr. doi: 10.1002/fsn3.1907 – volume: 31 start-page: 1359 year: 2003 ident: B112 article-title: Lipoprotein Metabolism in Patients with Severe Sepsis publication-title: Crit. Care Med. doi: 10.1097/01.ccm.0000059724.08290.51 – volume: 52 start-page: 221 year: 2020 ident: B28 article-title: The COVID-19 Pandemic and its Impact on Plastic Surgery in Europe - an ESPRAS Survey publication-title: Handchir Mikrochir Plast. Chir doi: 10.1055/a-1169-4443 – volume: 63 start-page: 1678 year: 2020 ident: B43 article-title: Decreased Serum Albumin Level Indicates Poor Prognosis of COVID-19 Patients: Hepatic Injury Analysis from 2,623 Hospitalized Cases publication-title: Sci. China Life Sci. doi: 10.1007/s11427-020-1733-4 – volume: 199 start-page: 854 year: 2019 ident: B108 article-title: Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.201806-1157OC – volume: 115 start-page: 3 year: 2001 ident: B51 article-title: Interleukin 6 and Haemostasis publication-title: Br. J. Haematol. doi: 10.1046/j.1365-2141.2001.03061.x – volume-title: Cholesterol Metabolism--Impact for SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies ident: B120 – volume: 79 start-page: 8 year: 1989 ident: B29 article-title: High-density Lipoprotein Cholesterol and Cardiovascular Disease. Four Prospective American Studies publication-title: Circulation doi: 10.1161/01.cir.79.1.8 – volume: 63 start-page: 253 year: 1995 ident: B76 article-title: Reconstituted High-Density Lipoprotein Neutralizes Gram-Negative Bacterial Lipopolysaccharides in Human Whole Blood publication-title: Infect. Immun. doi: 10.1128/iai.63.1.253-258.1995 – volume: 9 start-page: 761 year: 2020 ident: B126 article-title: Transcriptomic Characteristics of Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells in COVID-19 Patients publication-title: Emerg. Microbes Infect. doi: 10.1080/22221751.2020.1747363 – volume: 21 start-page: 431 year: 2002 ident: B12 article-title: Risk of Nosocomial Infections and Effects of Total Cholesterol, HDL Cholesterol in Surgical Patients publication-title: Clin. Nutr. doi: 10.1054/clnu.2002.0575 – volume: 10 start-page: 209 year: 2021 ident: B16 article-title: Native High-Density Lipoproteins (HDL) With Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity publication-title: Antioxidants doi: 10.3390/antiox10020209 – volume: 17 start-page: 2158 year: 1997 ident: B96 article-title: HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL publication-title: Atvb doi: 10.1161/01.atv.17.10.2158 – volume: 132 start-page: 825 ident: B103 article-title: Reconstituted High-Density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis publication-title: Anesthesiology doi: 10.1097/aln.0000000000003155 – volume: 17 start-page: 743 year: 2003 ident: B81 article-title: HDL Counterbalance the Proinflammatory Effect of Oxidized LDL by Inhibiting Intracellular Reactive Oxygen Species Rise, Proteasome Activation, and Subsequent NF‐κB Activation in Smooth Muscle Cells publication-title: FASEB j. doi: 10.1096/fj.02-0240fje – volume: 226 start-page: 108716 year: 2021 ident: B89 article-title: Activation of Classical and Alternative Complement Pathways in the Pathogenesis of Lung Injury in COVID-19 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2021.108716 – volume: 395 start-page: 1054 year: 2020 ident: B137 article-title: Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study publication-title: Lancet doi: 10.1016/s0140-6736(20)30566-3 – volume: 143 start-page: 921 year: 2021 ident: B109 article-title: Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis publication-title: Circulation doi: 10.1161/circulationaha.120.048568 – start-page: 00126 year: 2021 ident: B65 article-title: The Comparison of Oxidative Markers between Covid-19 Patients and Healthy Subjects publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2021.06.004 – volume: 224 start-page: 483 year: 2015 ident: B77 article-title: HDL in Infectious Diseases and Sepsis publication-title: Handbook Exp. Pharmacol. doi: 10.1007/978-3-319-09665-0_15 |
SSID | ssj0000399364 |
Score | 2.3723488 |
SecondaryResourceType | review_article |
Snippet | The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge. Managing a large number of acutely ill patients in a short time, whilst... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 720283 |
SubjectTerms | angiotensin-converting enzyme 2 COVID-19 HDL lipoproteins Pharmacology SARS-CoV-2 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA_iyYuou-LziwiLBzHapknaHF1d0WX9QFS8hTQf-EDahz4P7793Jn3q68W9CD0lKU1_mWRmkslvCPkVci9i6SVTLngmAi-ZzTxnQWnkt7PSp9QJF5fq7E78fZAPM6m-MCasowfugDt0qubauqiUr4SschtFbUXpuIO1t_bp6h7ovBlnKq3BqHeV6I4xwQvTh3H0aJH_k-cHJUel2lNEia-_Z2T2QyRndM7pElmcGov0qOvkMpkLzQrZve7Ypif79Pbz8tTLPt2l15881JMfJINqetM-BdpGivEc7ASj1ccT-m84ahNBw7Ch8Bxf3Z-fsFz_JHenf26Pz9g0QQJzQvAxK5HMUNqCa17B5LKWey6qooo8aleUVklRB4AMlDCXoahVrKOKmXIcYfR1sUrmm7YJa4QGxXXmtXaKB-HwSoL3UCSLoCuwWMoByd7RMm7KHo5JLJ4MeBEIsEkAGwTYdAAPyN7HK6OOOuOrxr9xCD4aIut1KgBZMFNZMP-ThQHZeR9AA7MEjz5sE9rXFwOOE_hlYA3JASl7I9v7Yr-mGT4mvm1c9ERRrX9HFzfIAv417g7napPMj59fwxaYNeN6O0nwG_Zh9Ys priority: 102 providerName: Directory of Open Access Journals |
Title | The Role of High-Density Lipoprotein in COVID-19 |
URI | https://www.proquest.com/docview/2557537825 https://pubmed.ncbi.nlm.nih.gov/PMC8322438 https://doaj.org/article/c6b29acf66d84581af4ba47c2c036bd9 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKuXBBUEAsj8pIqAdUl8Rx7PiAUB9UBVGoUBf1Zjl-0JVWybK7ldh_z4yTbRupQkLKJbaTyDMZfzN-fEPI25B7EZUvmXTBMxG4YjbznAWpkd_Olj6lTjj9Jk_G4stFebFB1umtegEu7gztMJ_UeD7d-_N79REM_gNGnIC37-Ps0iK1J8_3FEe8vEfuAzApTGhw2nv7aWBGME6EUjngLNOAbd06591vGSBVIvQfeKHDPZS3QOn4EXnYe5N0v1P_Y7IRmi2yc9bRUa926fnN6arFLt2hZzdE1asnJINq-qOdBtpGihs-2BFuZ1-u6NfJrE0MDpOGwnX4_efnI5brp2R8_On88IT1GRSYE4IvmUK2w9IWXPMKrM9a7rmoiiryqF2hrCxFHarcAkrzMhS1jHWUMZOO5zYKXxfPyGbTNuE5oUFynXmtneRBODyz4D0UlUXQFbg0akSytbSM6-nFMcvF1ECYgQI2ScAGBWw6AY_Iu-tHZh23xr8aH6AKrhsiLXYqaOe_TG9lxsmaa-uilL4SZYWdqK1QjjsA6trrEXmzVqABM8K1EduE9mphILKCwA3cpXJE1ECzgy8Oa5rJZSLkxlFRFNWL_-nPS_IA73CaOJevyOZyfhVeg3-zrLfTvMB2-nf_Ammm9xY |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+High-Density+Lipoprotein+in+COVID-19&rft.jtitle=Frontiers+in+pharmacology&rft.au=Wang%2C+Guyi&rft.au=Deng%2C+Jiayi&rft.au=Li%2C+Jinxiu&rft.au=Wu%2C+Chenfang&rft.date=2021-07-16&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=12&rft_id=info:doi/10.3389%2Ffphar.2021.720283&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fphar_2021_720283 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |